A protein called PERK may be a target for treating progressive supranuclear palsy – Science Daily

A protein called PERK may be a target for treating progressive supranuclear palsy
Science Daily
Scientists at the German Center for Neurodegenerative Diseases (DZNE) and the Technical University of Munich (TUM) have now discovered a molecular mechanism that may help in the search for effective treatments. Their study focusses on a protein called ...

Read the original:

A protein called PERK may be a target for treating progressive supranuclear palsy - Science Daily

Related Posts

Comments are closed.